Wockhardt rose 2.52% to Rs 1,580 at 11:36 IST on BSE after the company said that the UK health regulator completed inspection of its plant at Chikalthana in Maharashtra without issuing any critical observations on the facility.
The announcement was made after market hours yesterday, 5 October 2015.
Meanwhile, the BSE Sensex was up 22.80 points, or 0.09%, to 26,808.35.
On BSE, so far 1.61 lakh shares were traded in the counter, compared with an average volume of 2.84 lakh shares in the past two weeks.
The stock hit a high of Rs 1,597.50 and a low of Rs 1,569 so far during the day. The stock hit a 52-week high of Rs 2,000 on 8 April 2015. The stock hit a 52-week low of Rs 722.40 on 17 October 2014.
Also Read
Wockhardt announced that inspection of its manufacturing unit at L-1, Chikalthana, Aurangabad by UK Medicines and Healthcare products Regulatory Agency (MHRA) has since been completed and there were no critical observations.
On a consolidated basis, net profit of Wockhardt rose 472.43% to Rs 114.20 crore on 15.08% rise in net sales to Rs 1140.65 crore in Q1 June 2015 over Q1 June 2014.
Wockhardt is a research based and technology intensive global pharmaceutical and biotechnology company.
Powered by Capital Market - Live News
